What does AURORA CANNABIS INC (ACB) do?

AURORA CANNABIS INC (ACB) is a publicly traded company in the Healthcare sector.

What sector does ACB operate in?

AURORA CANNABIS INC operates in the Healthcare, specifically within the Drug Manufacturers—Specialty & Generic industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ACB earnings analysis?

AlphaOS publishes an earnings intelligence page for AURORA CANNABIS INC (ACB) covering results, guidance context, and AI-assisted analysis. See /stocks/ACB/earnings. Content is for research and education — not investment advice.

ACB

AURORA CANNABIS INC

Healthcare · Drug Manufacturers—Specialty & Generic

$4.03Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Strong evidence · 3 sources

Why it matters

AURORA CANNABIS INC shows accelerating business momentum based on AlphaOS pipeline evidence, with strong management execution.

Why it matters: Revenue +17% YoY in Q2 FY2025.

TrajectoryAccelerating

ExecutionStrong

CapitalReinvesting

1 signal not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +17% YoY in Q2 FY2025
Revenue Growth

Pipeline evidence · 0d ago

ACB's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ACB.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2027

Full ACB earnings analysis

Reported figures for AURORA CANNABIS INC — research only, not investment advice.

Revenue YoY: +32.0%

Latest Intelligence

Updated September 30, 2026

What happened recently for AURORA CANNABIS INC (ACB) — events, not interpretation.

Event: Reported Q1 2027 revenue +32% YoY.
Also: Last session September 29, 2026 at $4.03.
Source: Q1 2027 earnings

Research & analysis only — not investment advice.

Building company intelligence…

AURORA CANNABIS INC (ACB)

Healthcare · Drug Manufacturers—Specialty & Generic

Investment Snapshot above is the primary AlphaOS analysis for AURORA CANNABIS INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Drug Manufacturers—Specialty & Generic
Market cap:: $226.62M
Revenue:: $98.02M

ACB earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow AURORA CANNABIS INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.

ACB